Targeting dysregulated kappa-opioid receptors reduces working memory deficits in alcohol use disorder - USF Health NewsUSF Health News
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Antagonists of the kappa opioid receptor - ScienceDirect
The Kappa Opioid Receptor: From Addiction to Depression, and Back | Semantic Scholar
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
κ-opioid receptor - Wikipedia
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction - ScienceDirect
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction | Neuropsychopharmacology
Focusing on the Opioid System for Addiction Biomarker Discovery: Trends in Molecular Medicine
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
Kappa-opioid receptor-selective antagonism by zyklophin.... | Download Scientific Diagram
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Drug Addiction Pipeline Drugs Market by Stages, Target & Key Players, 2022 Update
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
